Indian dermatology therapeutics Market

A large database of syndicated market research
studies in pharmaceuticals and healthcare sector
on global, regional as well as country level. We
also provide customized research reports
tailormade to suit your needs.
Lifesciences Market
Research Reports you
can trust
www.insights10.com

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses.
Get Insights to take
informed Business
Decisions
www.insights10.com

Market Research Reports
across various domains of healthcare
Healthcare
Services
OTC &
Nutraceuticals
Pharmaceutical
(Diseases & Drugs)
Digital
Health
Medical
Devices

insights on which
our reports are
based
1
2
3
4
5
6
10
9
8
7
Market Overview
Growth Drivers and
Growth Restraints
Epidemiology &
Disease type
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policy and
Regulatory Landscape
Market Segmentation Reimbursement Scenario
Future Development Growth

Indian Dermatology
Therapeutics
Market Analysis
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2021 – 2030)
www.insights10.com

This report presents a strategic analysis of the Indian Dermatology
Therapeutics market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends
and insights, growth and demand drivers, challenges & future outlook,
etc. This is one of the most comprehensive reports about the Indian
Dermatology Therapeutics Market, offering unmatched value, accuracy
and expert insights.

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

The report is prepared
using a proven
methodology and
insightful research.
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make smarter
business and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more.
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works.
Easy to read
What Kind of Data is Presented
in This Report?
This report presents data, which is:
www.insights10.com

10 A Sample Report on Indian Dermatology Therapeutics Market I Confidential
Table of Contents
1. Methodology and Scope…………………………………………………………………….…………………………………………………..…..12
1.1 Research Methodology
1.2 Analysis Methodology
1.3 Research Approach
1.4 Key benefits for stakeholders
2. Indian Dermatology Therapeutics Market Overview…………………………………………..…………………………………....…...........18
2.1 Background
2.2 Introduction
2.3 Market size and forecast
3. Market Growth Drivers and Restraints …………………………………………………………………….…………………………………….22
3.1 Market Growth Drivers
3.1.1 Increase in incidence of skin diseases
3.1.2 Awareness regarding skin diseases
3.1.3 Rising number of working women
3.1.4 Demand for topical dermatology drugs
3.1.5 Easy accessibility of the products
3.1.6 Government Initiatives

Table of Contents (continued)
3.2 Market Restraints
3.2.1 Serious side effects of drugs
3.2.2 Competitors in Market
4. Major Types of Dermatology Diseases…..…………………………………………………………………………………..………………..31
4.1 Eczema
4.2 Tinea Pedis
4.3 Urticaria/Angioedema
4.4 Atopic Dermatitis
4.5 Acne
5. Dermatology Market Segmentation………………………..…………………………………………………………………..……….….….34
5.1 By Disease Type
5.2 By Drug Class
5.3 By Route of Administration
5.4 By End Users
5.5 By Distribution Channel

Table of Contents (continued)
6. Dermatology Major Products Market Share…………………………………………………………...…………..….......….….42
6.1 Market Analysis, Insights and Forecast - By Revenue
7. Competitive Landscape……………………………………………………………………………………………………………....44
7.1 Major Players
7.2 Products in Pipeline
8. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….………………………..…...48
8.1 Sun Pharma
8.2 GlaxoSmithKline
8.3 Glenmark Pharmaceuticals
8.4 Galderma
8.5 USV Private Limited
9. Healthcare Policies and Regulatory Landscape………………………………….……………………………………………..59
9.1 Regulatory Framework of Indian Dermatology Therapeutics Market
10. Factors Driving Future Growth……………………………………………………………………………………………….…...62
10.1 Strategic recommendations

A Sample Report on Indian Dermatology Therapeutics Market
1. Methodology and Scope

1.1 Research Methodology
 Insights 10’s research methodology delves deep into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
 We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conducted extensive data mining, referring to verified data sources such as independent studies,
government and regulatory published material, technical journals, trade magazines, and paid data sources
 For forecasting, the following parameters were considered:
 Market drivers and restraints along with their current and expected impacts
 Technological scenario and expected developments
 End use industry trends and dynamics
 Trends in the consumer behavior
 Regulatory scenario and expected developments
 Current capacity and expected capacity additions up to 2030
 We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the
expected market growth rate
 We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
 All our estimates and forecasts were verified through exhaustive primary research with the Key Industry Participants (KIPs)

1.2 Analysis Methodology
• Final Market Size Break-up to Rest of
Segmentation i.e., Product and Services,
Type, Specialty, Delivery Mode and
Geography, etc
• Arriving at the Market Size of each Segment
• Data Validation with Primary Interviews
• Final Market Size
• Validation from Primary Interview
• Summation of Revenue Generated from
Companies to Arrive at Total Market Size
• Revenue Generated by Products and
Services offered by Companies
Top Down Analysis
Bottom-up Analysis

1.3 Research Approach
The data presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Data Collection
• Primary Interviews (Industry Participants,
Outside experts)
• Secondary Data
Company Reports and Publications,
Government Data, Financial Reports of Key
Industry Players, Press Releases, Scientific
and Industry Publications and Whitepapers
Market Data Analysis &
Statistical Model
• Market Trends
• Market Sizing and Analysis
• Data Triangulation & Validation
Market Trends such as Drivers, Restraints,
Opportunities, Challenges. An intensive
cross-verification and validation process
Interpretation and
Presentation
• Analysis & Interpretation
• Insights
• Presentation & Reporting
The information gathered is then analyzed
and synthesized. The market research
report is presented in different forms such
as charts by using a scientific approach for
easy understanding

1.4 Key Benefit for Stakeholders from this report
The study provides an in-depth analysis of the Indian Dermatology Drug Market with current trends and future estimations to
elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

“The Rs 8,700 crore dermatology market has
been the fastest-growing therapy segment in the
domestic market over the last three years,
outperforming the larger categories of diabetes
and cardiac treatments. Changing climatic
conditions, higher pollution and increasing
disposable incomes have contributed to the
growth”

2. Indian Dermatology Therapeutics Market Analysis :
Market Overview

2.1 Background
 Skin diseases are responsible for significant morbidity worldwide, but they do not get due importance
in national health planning and policies in several countries. Although mortality due to skin diseases is
low, they contribute to significant disability, and the non-fatal burden of skin and subcutaneous
diseases is more than that of cardiovascular diseases in India
 In India, there were 4.07 million (95% uncertainty interval 2.65–6.19 million) years lived with disability
due to skin and subcutaneous diseases in 1990, which increased to 6.26 million (95% uncertainty
interval 4.12-9.35 million) in 2017. Although the number of years lived with disability has increased by
53.7% between 1990 and 2017, the increase in age-standardised years lived with disability rates was
only 1.52%
 The high burden of skin and subcutaneous diseases demand that they be given due importance in the
national programmes and health policy of India

2.2 Introduction
 As people age, the risk of developing skin-related disorders increases, due to factors, such as changes
in the connective tissue, reduction in the skin’s strength and elasticity, and reduction in secretions from
sebaceous glands.
 Skin conditions pose a significant threat to patient’s well-being, mental health, ability to function, and
social participation
 In India, Dermatitis (atopic, seborrheic and contact) contributed maximum to years lived with disability
(1.40 million, 95% uncertainty interval:0.82–2.21) followed by urticaria (1.02 million, 95% uncertainty
interval 0.06-1.44) with percentage increases of 48.9% and 45.7%, respectively
 Infections and infestations contributed to nearly 30 % of the total years lived with disability due to skin
and subcutaneous diseases (fungal skin diseases- 12.6%, viral skin diseases-10.0% and scabies-
10.3%)

Indian Dermatology Therapeutics Market Size INR Mn)
2022-2030F
2.3 Market Size & Forecast
 Indian Dermatology Therapeutics market size stood at
around USD XX million in 2021 and is projected to reach
USD XX million by 2030, exhibiting a CAGR of around
XX.X% during the forecast period
 The derma market has grown by approximately 4.5% per
year on an average (CAGR). The current market size of
the Dermatology segments in India is approximately INR
xx crores, growing rapidly at about xx%. In terms of
revenue, the face care products was dominating the
market with 57.22% share in 2020
 The increasing incidence of Dermatology diseases and
increasing levels of awareness-related disease
progression, etiology, and available therapies are leading
to a high growth of Dermatology therapeutics in India.
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Key Analysis
$XX
$XX

Growth Drivers and Growth Restraints

3.1 Market Growth Drivers
Market
Restraints
Implementation of pregnancy
controlling activities
Government
Initiatives
Rise in the
incidence of skin
diseases
Awareness
regarding Skin
Diseases
Rising number
of working
women
Demand for Topical
Dermatology drugs
Easy
Accessibility of
the products
Market
Drivers

Market Growth Drivers
3.1.1 Rise in the incidence of skin diseases
• With the rise in the aging population,
Dermatology care is likely to receive particular
attention.
• As people age, the risk of developing skin-
related disorders increases due to factors,
such as changes in the connective tissue,
reduction in the skin's strength and elasticity,
and reduction in secretions from sebaceous
glands.
Sample

Market Growth Drivers (continued)
• Increase in improvement of awareness regarding
skin health in India
3.1.2 Awareness regarding skin diseases
• With the increasing consciousness among Indians
regarding their appearance, they are doing more
than ever to take care of their skin, which is
propelling the demand for a range of derma
cosmetic products.
Sample

3.1.3 Rising number of working women
• Rising number of working women and is
leading to higher demand for personal care
product.
Sample
Sample
Sample

3.1.4 Demand for Topical Dermatology drugs
Sample
• Drugs such as anti-inflammatory agents, anti-infective,
local anaesthetics, cleansers, and emollients to treat
acne.
• Demand for topical Dermatology drugs has increased due
to increased population. It directly affects the growth of
Dermatology Market.
Sample

3.1.5 Easy Accessibility of the products
Sample
• Easy accessibility of the products through company
websites and online channels, and doorstep delivery are
driving the market.
Sample Sample

3.1.6 Government Initiatives
Sample
The initiatives taken by the government are expected to
contribute to the growth of the dermatology market in
India.
For example, PMJY, is funded tertiary health coverage
scheme, which provides cashless surgical treatments for
various ailments, including Dermatology problems.
Sample

3.2.1 Serious side effects
3.2 Market Restraints
 Serious side effects of certain classes of
therapeutic drugs are expected to restrain the
market growth in the near future
3.2.2 Competitors in market
 Due to the presence of numerous globally
operating companies, the Indian skincare derma
cosmetics market is fragmented, which is
prompting the players to launch new products
Sample Sample

4. Indian Dermatology Therapeutics Market Analysis:
Major Dermatology Diseases

4. Major Dermatology Diseases
Eczema Tinea Pedis
About 10% of the total
population may be affected
by dermatophyte infections
of the toe clefts.
The condition is more
common in adult males than
in females.
In India, at least one in five
children suffer from
eczema, also known as
atopic dermatitis. “Since
the underlying causes are
incompletely known, we
undertook a study to
identify correlates of the
disease,”
Chronic urticaria is a relatively
common condition in India and most
cases have no specific allergic trigger
and remain idiopathic.
Autoimmune causes have been
found to be associated with up to 30-
40% cases.
It is important to look for physical
urticarias such as pressure urticaria
in chronic cases.
Urticaria ⁄Angioedema
4.1 4.2 4.3

Major Dermatology Diseases
Atopic Dermatitis Acne
Atopic Dermatitis (AD) is hereditary
and the most common type of
eczema. It is estimated that up to
17 per cent of Canadians will
suffer from AD at some point in
their lives. AD almost always
starts in infancy or before age 5
In India, about 12 percent between 20 to
29 years of age had acne problems.
Excess oil production, pores becoming
clogged by sticky skin cells, bacteria
and inflammation directly contributed to
acne problems.
4.4
4.5
4.4

Market Segmentation

Snapshot of Dermatology Market Segmentation
Market
Restraints
By Disease Type
By Drug Class
By Route Of Administration
By End Users
Dermatology
Market
Segmentation
By Distribution Type

Snapshot of Dermatology Market Segmentation
DISEASE TYPE DRUG CLASS
ROUTE OF
ADMINISTRATION END USERS DISTRIBUTION CHANNEL
• Acne
• Dermatitis
• Psoriasis
• Skin Cancer
• Alopecia
• Rosacea
• Anti-infectives
• Corticosteroids
• Calcineurin
inhibitors
• Retinoids
• Antirheumatic
• Oral
• Topical
• Parenteral
Administration
• Home Care
• Hospital
• Dermatology
Clinics
• Pharmacy Store
• Retail Store
• Online

 Approximately 80 percent of Indian are affected by acne
between the onset of puberty and 30 years of age. By the
end of 2026, the number of people affected by acne in
India is estimated to reach 23 million at a compound
annual growth rate (compound average growth rate) of
0.5 percent.
 In India, the incidence of melanoma of the skin in the
North region is 1.62 for males and 1.21 for females for
every 1,00,000 people. The overall incidence of
nonmelanoma skin cancer is the highest in the Northeast
region, going as high as 5.14 for men and 3.98 for women
for every 1,00,000 people.
 Content
5.1 Market Segmentation: By Disease Type
Indian Dermatology Therapeutic Market Share by Disease type
2022
Key Insights
Acne Eczema Atopic
Dermatitis
Skin Cancer Tinea Pedis

 The biologics segment is expanding at a large scale
during the forecast period owing to the increasing
regulatory approval of biologics.
 Anti-infectives are medicines that work to prevent or treat
infections, they include antibacterials, antivirals,
antifungals and antiparasitic medications.
 Topical corticosteroids are effective in a number of
dermatoses. Dermatotherapy has always been a
combination of art and science.
Sample
5.2 Market Segmentation: By Drug Type
Indian Dermatology Therapeutics Market Share by Drug Type
2022
Key Insights
Anti-infectives Corticosteroids Calceneurin
Inhibitors
Retinoids Antirhematic

5.3 Market Segmentation: Route of Administration
Key Assumptions
Topical
Oral
Parenteral administration
Route of Administration
Topical Oral Parenteral administration
 In Indian dermatology therapeutics market, the topical
segment held a large share of the market owing to the
rise in the demand for topical Dermatology drugs such as
anti-inflammatory agents, anti-infective, local anesthetics,
cleansers, and emollients to treat acne.
Indian Dermatology Therapeutics Market Share by Route of Administration
2022

5.4 Market Segmentation: By End Users
Indian Dermatology Therapeutics Market Share by End Users
2022
 Hospitals provide medical, diagnostic, and treatment
services to inpatients and some outpatient dermatology
services, which is holding largest share of the
dermatology market
 Large number patients are being treated at home, which
is holding market share following hospitals in dermatology
market
Key Insights
End Users
Hospitals Homecare Dermatology Clinics

5.5 Market Segmentation: By Distribution Channels
Indian Dermatology Therapeutics Market Share by Distribution Channel
2022
 It is expected that the pharmacy and retail store category will
lead throughout the forecast period.
 This is due to the availability of a broad range of over-the-
counter derma products, which are available in the
pharmacy and retail stores.
 However, with the increasing trend toward online shopping
and due to Covid-19 impact, people are preferring to make
an online purchase and due to this online category is also
witnessing faster growth in the dermatology market
Key Insights
Pharmacy Store Retail store Online

Dermatology Major Products Market Share

Top Brands in Dermatology Therapeutics Market
6.1 Major Dermatology Products Market Share
Key Insights
Indian Dermatology Therapeutics Major
Products Market Share
Brand 1 Brand 2 Brand3 Brand 4

7. Indian Dermatology Market Analysis :
Competitive Landscape

7.1 Major Players Revenue (Current and Forecast)
2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Sun Pharma XX - - - - - - - -
GlaxoSmithKline
XX - - - - - - - -
Glenmark
Pharmaceuticals
XX - - - - - - - -
Galderma India Private
Limited
XX - - - - - - - -
USV Private Limited. XX - - - - - - - -
Revenue of Major Dermatology Market Players ($Bn)

Key Players by Revenue Growth and Market Share
Sun Pharma
GlaxoSmithKline
Glenmark Pharmaceuticals
Galderma India Private
USV Private Limited.
Dermatology Therapeutics($Bn)
Revenue Market Share Growth

7.2 Products in Pipeline
 Lipidor AB has penned an agreement with Cadila
Pharmaceuticals to conduct a Phase III study for
Lipidor’s drug candidate AKP-02. AKP-02 is an
antipsoriasis medicine that combines the active
substances calcipotriol and betamethasone with
Lipidor’s spray-based AKVANO technology
 Content
Sample

8. Key Company Profiles

8.1 Sun Pharma
Company Profile
Company Name: Sun Pharma
Year of Establishment: 1983
Headquarter: India
Revenue: US$4.5 Bn
Website www.sunpharma.com
Sample

Sun Pharma (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030
XX
XX
Sample
1 2 3 4

Sample
Headquarter: United Kingdom
Revenue: $xx Bn
Website: www.gsk.com
Company Profile
8.2 GlaxoSmithKline
Company Name: GlaxoSmithKline

GlaxoSmithKline (continued)
XX
XX
1 2 3 4
Analysis
Sample

Sample
Company Name: Glenmark Pharmaceuticals
Headquarter: Mumbai, India
Revenue: US$xx Bn
Website: www.glenmarkpharma.com
Company Profile
8.3 Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (continued)
Analysis
Revenues ($Bn), 2022-2030)
XX
XX
Sample
1 2 3 4

8.4 Galderma India Private Limited
Company Profile
Company Name: Galderma India Private Limited
Headquarter: SA Lausanne, Switzerland
Revenue: $ 3.417 Bn
Website: www.galderma.com
Sample

Galderma India Private Limited (continued)
Analysis
XX
XX
Sample
1 2 3 4

Sample
Company Name: USV Private Limited
Headquarter: Mumbai, India
Revenue: $ 2.3 Bn
Website: www.usvindia.com
Company Profile
8.5 USV Private Limited

USV Private Limited (continued)
Analysis
XX
XX
Sample
1 2 3

9. Healthcare Policy and Regulatory Landscape

9.1 Regulatory Framework of India Dermatology Therapeutics Market
The Indian Association of Dermatologists,
Venereologists and Leprologists (IADVL),
the largest representing official society of
Indian Dermatologists was established in its
present form on 28th January, 1973.
The journey that culminated in the
formation of IADVL as we know it today
took its first flight in 1947 when Dr. UB
Narayan Rao, conceived the idea to create
an association of Dermatologists and
Venereologists.
IADVL is the national association of Indian
medical specialists who manage patients
with skin disorders, sexually transmitted
infections (STIs) or leprosy. The association
works for the betterment of the specialty by
holding academic meetings, printing a
journal (print version &online).
A framework regarding rules was approved on
July 26, 1948 and the association started its
work on establishing local branches in other
states. IADVL also happens to be the world’s
2nd largest Association of Dermatologists
behind the American Academy of
Dermatology.

Regulatory Framework of India Dermatology Therapeutic Market
• The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) organization is
ever committed to serving the public in the domains of dermatology. In lieu of this, IADVL
observes several days of clinical significance including Leprosy day, Vitiligo day, World Skin
Health Day to name a few.
• IADVL has a wing dedicated to Community outreach programs which not only help in taking
quality skin care to the rural remote areas but also promote awareness on skin hygiene, equipping
the local medical personnel to manage the common skin conditions and to refer the complicated
cases to higher referral centers.
• Indian Dermatology Online Journal (IDOJ) is a bimonthly open access print journal of Indian
Association of Dermatologists, Venereologists and Leprologists (IADVL).

10. Future Driving Growth

10. Future Opportunities
.
The prime strategically activities
within the market are initiated by the
key players which incorporate product
developments, mergers, and
acquisitions, partnerships, etc.
The new vendors within the Dermatology
Diagnostic Devices and Therapeutics market face
powerful competition from established
international vendors as they struggle with
technological innovations, dependability, and
quality problems
The Indian Journal of Dermatology has
always played a progressive role of
acting as a medium for the ever-
changing developments of scientific
research in dermatology in this part of
the world
Future
Opportunities

10.1 Strategic Recommendations
Dermatology in the new
millennium must focus on the
needs, hopes, and
satisfaction of those who
consider themselves to have
skin liaments. Governments
can change this by declaring
some unidentified needs to be
important and thus fundable,
while others are deemed
unimportant.
The importance of skin to the
individual will not diminish,
and funding agencies should
recognize this. The costs of
treating skin diseases will
always be an issue, and the
case for treating skin
diseases will have to be
made in a competitive world
filled with many life-
threatening diseases.
Dermatologists may
themselves opt out of treating
conditions which governance
deems important. An example
would be all breaks in surface
continuity of the skin which
other professions might wish
to take over as leg ulcers, the
diabetic foot ulcer, the
pressure sore, or burns.

We would be happy to help.
www.insights10.com
Please email
info@insights10.com or
Call +91 9820827455

THANK YOU
www.insights10.com
We truly appreciate your business and
look forward to serving you.

Indian dermatology therapeutics Market

Indian dermatology therapeutics Market

Recommended

Recommended

More Related Content

Similar to Indian dermatology therapeutics Market

Similar to Indian dermatology therapeutics Market (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Indian dermatology therapeutics Market